Category: Pfizer BioNTech

UK May Give Healthy 12- to 15-Year-Olds COVID-19 Vaccine Despite Scientific Advice

The UK government is yet to decide whether to offer the Pfizer-BioNTech COVID-19 vaccine to all 12- to 15-year-olds, vaccines minister Nadhim Zahawi said on Sunday. It comes after the government’s independent advisory body on vaccination and immunisation advised against offering the vaccine to healthy children in this age group. “We have not made any decisions,” Zahawi told Sky News’s…


UK Vaccines Advisory Body Not Recommending CCP Virus Vaccines to Healthy Children Under 16

The UK government’s advisory body on vaccination has decided not to recommend universal CCP virus vaccination for 12–15-year-olds, contrary to expectations. The Joint Committee on Vaccination and Immunisation (JCVI) on Friday said it’s taking a “precautionary approach” because children have a very low risk of getting seriously ill from the CCP (Chinese Communist Party) virus—two in a…


NTD Evening News Full Broadcast (Aug. 23)

The FDA approves the Pfizer vaccine as President Joe Biden calls for new vaccine mandates, the pressure is on to evacuate the tens of thousands of people waiting to leave Afghanistan, and the death toll from the flash floods in Tennessee is rising.


Vaccines Doesn’t Reduce Peak Viral Load When Infected With Delta Variant, UK Study Suggests

Those who caught the Delta Variant of the CCP virus after being fully vaccinated carry a similar level of peak viral burden with their unvaccinated counterparts, a new UK analysis suggests. This suggests that a vaccinated and an unvaccinated individual, while infected with the variant, would shed similar amounts of the virus at any given time…


With Delta Variant, Vaccines Don’t Reduce Peak Viral Load: UK Study

Those who caught the Delta Variant of the CCP virus after being fully vaccinated carry a similar level of peak viral burden with their unvaccinated counterparts, a new UK analysis suggests. This suggests that a vaccinated and an unvaccinated individual, while infected with the variant, would shed similar amounts of the virus at any given time…


Vaccine Antibodies May Start to Fall Six Weeks After Second Shot: UK Study

Antibody levels generated by two doses of the Oxford/AstraZeneca or Pfizer/BioNTech coronavirus vaccine may start to fall six weeks after the second jab, and for some could drop by up to 50 percent in less than three months, research suggests. University College London’s (UCL) Virus Watch study analysed blood from 552 vaccinated people mostly in…


Vaccine Makers Face Fresh Challenges as COVID Variants Weaken Vaccine Efficacy

Scientists have already started looking for new vaccine candidates for the CCP virus as the mRNA vaccines, such as Pfizer and Moderna, become less effective against increasingly contagious coronavirus mutations, according to new research. The report, published in the U.S.-based New England Journal of Medicine at the beginning of July found that vaccine-induced antibodies were 2.9…


BioNTech COVID-19 Vaccine Produces 10 Times More Antibodies Than China’s Sinovac: Study

A new study by researchers in Hong Kong has found that recipients of BioNTech’s Comirnaty COVID-19 vaccine generate 10 times more antibodies than the Chinese CoronaVac vaccine made by Sinovac. The study reported that even after receiving their first BioNTech dose, recipients’ antibody levels were higher than those who had received two doses of Sinovac. The…


Business Leaders Urge the Government to Set Realistic Vaccine Targets

Australia’s business leaders are pressing the state and federal government to set realistic vaccine targets to reopen Australia after 18 months of pandemic economic pain. This comes after Prime minister Scott Morrison announced the four-step plan at the National Cabinet meeting last Friday, with each phases to be triggered by the achievement of a vaccination…


European Regulators OK Pfizer Vaccine for Children 12-15

BERLIN—The European Medicines Agency on Friday recommended that the use of the coronavirus vaccine made by Pfizer and BioNTech be expanded to children ages 12 to 15, a decision that offers younger and less at-risk populations across the continent access to a COVID-19 shot for the first time during the pandemic. Marco Cavaleri, who heads…